• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

CJ CheilJedang’s Brand Value Reaches 1.1866 Trillion Won…Ranked No. 1 Among Consumer Goods Companies

CJ CheilJedang has once again demonstrated its competitiveness as a leading brand in the domestic food industry by being named to the “2026 Best Korea Brands” list.#CJ CheilJedang announced on the 12t…
  • 2026-06-12 08:54:38
  • kim mi-kyung
Lifestyle

"From Diagnosis to Treatment"... FutureChem: What Is the Strategy to Complete the Puzzle with Therapeutic Radiopharmaceuticals?

#FutureChem has decided on a final round of fundraising ahead of its full-scale revenue generation and has secured a cash cow, allowing it to accelerate the development of FC705, a radiopharmaceutical…
  • 2026-06-12 08:21:05
  • Kim Jinsoo
Lifestyle

NextBio’s ‘Nexpire F’ Demonstrates Potential for Endless Evolution... Proven by a Series of Clinical Successes

#NextBioMedical is reshaping the medical device market landscape, centered on its knee osteoarthritis treatment, NexSphere F. This is because NexSphere F, which started as a treatment for knee osteoar…
  • 2026-06-12 08:21:03
  • YU JIN-HEE
Lifestyle

Dasan Pharmaceutical Accelerates CDMO Push in Japan... "Full-Scale Supply of Flagship Pellet Product Begins"

Dasan Pharmaceutical has successfully completed an on-site inspection by Japan’s Pharmaceutical and Medical Devices Agency (PMDA), accelerating its efforts to penetrate the local market and expand its…
  • 2026-06-12 08:21:02
  • YU JIN-HEE
Lifestyle

Vivozon Pharma and Lunit Rally on Commercialization and Nvidia Tailwinds [K-Bio Pulse]

Following a broad rally across Korea’s pharmaceutical and biotech sector the previous day, trading on June 10 shifted toward stock-specific momentum. Vivozon Pharm surged nearly 10% on expectations fo…
  • 2026-06-12 08:01:02
  • SONG YOUNG-DOO
Lifestyle

Bibozon Pharma and Lunit Rise in Tandem... Expectations for Commercialization and NVIDIA-Driven Expansion [Bio Spotlight]

Following a broad rally across the pharmaceutical and biotech sectors the previous day, the market on the 10th saw a differentiated trend centered on stocks with individual momentum. Vibozon Pharmaceu…
  • 2026-06-12 08:01:02
  • SONG YOUNG-DOO
Lifestyle

Hanwha Galleria Tightens the Reins on Five Guys Sale… Renews MOU with H&Q

#Hanwha Galleria is continuing the process of selling its stake in the artisanal burger brand Five Guys. As the exclusive negotiation period under the memorandum of understanding (MOU) signed last yea…
  • 2026-06-11 18:45:58
  • SIN SOO-JUNG
Lifestyle

Lotte Shopping to Pay Interim Dividend for Second Consecutive Year… Amounting to 36.7 Billion Won

#Lotte Shopping will pay an interim dividend this year, following last year’s payment. This year’s dividend per share has increased compared to last year. Lotte Shopping CI. (Photo = Lotte Shopping…
  • 2026-06-11 18:08:27
  • Kim Ji-woo
Lifestyle

Samil Pharmaceutical and Formosa Sign Exclusive License Agreement for Commercialization of ‘APP13007’ in Vietnam

#Samil Pharmaceutical announced on the 11th that it has signed an exclusive licensing agreement with Formosa, a Taiwan-based pharmaceutical company, through its Vietnamese subsidiary, securing exclusi…
  • 2026-06-11 16:14:02
  • KIM JI-WAN
Lifestyle

Chong Kun Dang to Foster Next-Generation Biotech... Building a 392.5 Billion Won ‘Complex Research Complex’ in Baegot, Siheung

#Chong Kun Dang, a leading traditional pharmaceutical company, is investing heavily to strengthen its capabilities in biopharmaceuticals, a key growth driver for the future. The company plans to estab…
  • 2026-06-11 15:50:44
  • YU JIN-HEE
prev 61 62 63 64 65 66 67 68 69 70 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English